UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 204

Sortiert nach

Diagnosis of severe respiratory infections in immunocompromised patients

Intensive care medicine, 2020-02, Vol.46 (2), p.298-314

2020

Volltextzugriff (PDF)

Intensive care nurses' experiences during the COVID‐19 pandemic: A qualitative study

Nursing in critical care, 2021-09, Vol.26 (5), p.397-406

2021

Volltextzugriff (PDF)

Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria

Intensive Care Medicine, 2015-05, Vol.41 (5), p.776-795

2015

Volltextzugriff (PDF)

Clinical management of sepsis can be improved by artificial intelligence: no

Intensive care medicine, 2020-02, Vol.46 (2), p.378-380

2020

Volltextzugriff (PDF)

Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU

Critical care medicine, 2014-06, Vol.42 (6), p.1423-1432

2014

Volltextzugriff (PDF)

When antibiotic treatment fails

Intensive care medicine, 2018, Vol.44 (1), p.73-75

2018

Volltextzugriff (PDF)

Risk Factors for Fluconazole-Resistant Candidemia

Antimicrobial Agents and Chemotherapy, 2010-08, Vol.54 (8), p.3149-3154

2010

Volltextzugriff (PDF)

Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project

Mycoses, 2019-04, Vol.62 (4), p.310-319

2019

Volltextzugriff (PDF)

Managing Acinetobacter baumannii infections

Current opinion in infectious diseases, 2019-02, Vol.32 (1), p.69

2019

Volltextzugriff (PDF)

Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients

Expert review of clinical pharmacology, 2018-02, Vol.11 (2), p.125-137

2018

Volltextzugriff (PDF)

Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital

Infection control and hospital epidemiology, 2009-03, Vol.30 (3), p.257

2009

Volltextzugriff (PDF)

A case of pan‐resistant Burkholderia cepacia complex bacteremic pneumonia, after lung transplantation treated with a targeted combination therapy

Transplant infectious disease, 2019-04, Vol.21 (2), p.e13034-n/a

2019

Volltextzugriff (PDF)

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)

Clinical microbiology and infection, 2022-04, Vol.28 (4), p.521-547

2022

Volltextzugriff (PDF)

Multiresistant Acinetobacter baumannii infections: epidemiology and management

Current opinion in infectious diseases, 2010-08, Vol.23 (4), p.332-339

2010

Volltextzugriff (PDF)

Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19

Frontiers in immunology, 2022-01, Vol.12, p.801410-801410

2022

Volltextzugriff (PDF)

How should we treat acinetobacter pneumonia?

Current opinion in critical care, 2019-10, Vol.25 (5), p.465

2019

Volltextzugriff (PDF)

European intensive care physicians' experience of infections due to antibiotic-resistant bacteria

Antimicrobial resistance & infection control, 2020-01, Vol.9 (1), p.1-1, Article 1

2020

Volltextzugriff (PDF)

Upraising Stenotrophomonas maltophilia in Critically Ill Patients: A New Enemy?

Diagnostics (Basel), 2023-03, Vol.13 (6), p.1106

2023

Volltextzugriff (PDF)

Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin

PloS one, 2016-12, Vol.11 (12), p.e0168468-e0168468

2016

Volltextzugriff (PDF)

“Balcony of Hope”: a key element of new intensive care units

Intensive care medicine, 2023-03, Vol.49 (3), p.379-380

2023

Volltextzugriff (PDF)

Combatting resistance in intensive care: the multimodal approach of the Spanish ICU "Zero Resistance" program

Critical care (London, England), 2015-03, Vol.19 (1), p.114-114, Article 114

2015

Volltextzugriff (PDF)

Timing of antibiotic therapy in the ICU

Critical care (London, England), 2021-10, Vol.25 (1), p.360-360, Article 360

2021

Volltextzugriff (PDF)

Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe sepsis: a prospective nation-wide study in Spain

Intensive care medicine, 2011-03, Vol.37 (3), p.444-452

2011

Volltextzugriff (PDF)

1 – 25 von 204

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(184)

Publikationsform

Sprache

Englisch
(183)
Spanisch
(30)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(145)
Life Sciences & Biomedicine
(144)
Humans
(123)
General & Internal Medicine
(75)
Critical Care Medicine
(74)
Female
(55)
Infectious Diseases
(55)
Male
(55)
Middle Aged
(52)
Microbiology
(48)
Mortality
(46)
Prospective Studies
(40)
Intensive Care
(39)
Intensive Care Units
(38)
Risk Factors
(37)
Aged
(34)
Anti-Bacterial Agents - Therapeutic Use
(32)
Pneumonia
(30)
Anesthesiology
(29)
Pediatrics
(29)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Diagnosis of severe respiratory infections in immunocompromised patients

Intensive care nurses' experiences during the COVID‐19 pandemic: A qualitative study

Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria

Clinical management of sepsis can be improved by artificial intelligence: no

Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)

Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU

When antibiotic treatment fails

Risk Factors for Fluconazole-Resistant Candidemia

Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project

Managing Acinetobacter baumannii infections

Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients

Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital

A case of pan‐resistant Burkholderia cepacia complex bacteremic pneumonia, after lung transplantation treated with a targeted combination therapy

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)

Multiresistant Acinetobacter baumannii infections: epidemiology and management

Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19

Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization

How should we treat acinetobacter pneumonia?

European intensive care physicians' experience of infections due to antibiotic-resistant bacteria

Upraising Stenotrophomonas maltophilia in Critically Ill Patients: A New Enemy?

Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin

“Balcony of Hope”: a key element of new intensive care units

Combatting resistance in intensive care: the multimodal approach of the Spanish ICU "Zero Resistance" program

Timing of antibiotic therapy in the ICU

Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe sepsis: a prospective nation-wide study in Spain

Suchergebnisse filtern